Singlera Genomics Inc
Singlera Genomics Inc. is developing and commercializing technologies relating to the analysis of circulating tumor methylated DNA (ctmDNA) for cancer screening, diagnosis, and personalized medicine. The company focuses on early cancer detection using high-throughput sequencing of methylated circulating tumor DNA.